retatrutide dosing clinical trial retatrutide dose escalation Guide for Researchers How Does Retatrutide Work? Doctor

Coexisting conditions affecting the tumor risk of GLP-1RAs Metabolic diseases Large-scale clinical studies have confirmed that the use of GLP-1RAs in diabetic populations does not increase the cancer risk occurrence

American Association for Cancer Research

Now, even as supply stabilizes and FDA shortage designations are lifted, compounded versions remain active in the market, raising critical questions around regulatory oversight, market sustainability, and long-term implications for branded manufacturers

Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas